It's true that Dr. Liau is the Lead Clinician and one of the developers of DCVax-L, but she's also one of the most highly respected and awarded people in her field. Who better to provide a view of what occurred in the trial. Almost every Dr. I've seen who'd critical of DCVax-L has been in some way working with the NVCR helmet, but it generally takes research to make that association as they try to make it sound as though they're unbiased.
Is this the guy you hold in high esteem? You cannot be serious. Does he know the whole c-suite of NVCR have been emptying their shares since the publication of the first paper on p3 trial results of DCVax-L which was May 28, 2018?